These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 16799407)
81. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138 [TBL] [Abstract][Full Text] [Related]
82. Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases. Ziegler A; Williams T; Yarid N; Schultz DL; Bundock EA J Forensic Sci; 2019 Jan; 64(1):275-280. PubMed ID: 29940703 [TBL] [Abstract][Full Text] [Related]
83. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps. Potti LG; Haines ST J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588 [TBL] [Abstract][Full Text] [Related]
90. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Pickup J; Keen H Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953 [TBL] [Abstract][Full Text] [Related]
91. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus]. Pfützner A; Berger S; Spinas G Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530 [TBL] [Abstract][Full Text] [Related]